Page 26 - GTM-2-3
P. 26

Global Translational Medicine                                       Critical roles for BRD4 identified in cancer




















            Figure  3.  An illustration of how BRD4 participates in double-strand break (DSB) repair. H4Ac and  γH2AX accumulate at DSBs, triggering BRD4
            recruitment. Assembly and activation of DNA repair machinery are facilitated and stabilized by BRD4, which facilitates and stabilizes 53BP1. This figure
                                         [24]
            is adapted from Drumond-Bock and Bieniasz .
            BRD4 is inhibited, cells can be exposed to stress-inducing   warranted to determine whether BRD4 plays a role in this
            agents due to a defective DNA damage checkpoint .   cancer type .
                                                                        [52]
                                                        [39]
            Thus, in view of the above, targeting the DNA damage
            repair pathway (DDR) in the treatment of cancers whose   6.2. BRD4 and NFκB signaling
            DNA damage repair components are defective could be a   BRD4 is involved in NFκB-dependent promoter and
            promising therapeutic approach [43-47] .           super-enhancer modulation, while NFκB signaling
                                                               blocks cognate transcriptional elements and activates
            5. The opposite roles of BRD4-L and BRD4-S         cognate promoters. P-TEFb can be recruited by BRD4 to
            BRD4 plays a crucial role in DDR [34,48,49] . The BRD4-L   NFκB-dependent acetylated histones through caspase-3 to
                                                                                                   [53]
            isoform regulates the transcription of genes involved   achieve primary response gene transcription . It is also
            in DNA repair and NHEJ genes [33,48] . It also binds and   possible that NFκB-dependent signaling in cancer cells
                                                                                              [52]
            modulates NHEJ protein complexes. In contrast, BRD4-S   may enhance orphan disease pathology .
            isoform has been reported to act as an endogenous inhibitor   BRD4 also modulates non-histone proteins, such
            of DNA repair complexes in the DDR (Figure  4) [38,48]    as coactivator RELA. Acetylated RELA binds to BRD4,
            and protect chromatin from the DDR machinery in the   increasing its transactivation activity in the nucleus.
            presence of DNA damage [48,50,51]  by stably binding to DNA   The previous studies have shown that RELA/p65 is
            molecules.  Further,  BRD4-S  recruits  condensation  II   phosphorylated at serine 276 and 536, thereby facilitating
            complex components, preventing DDR propagation by   the recruitment of p300/CBP histone acetyl-transferase
            inducing chromatin condensation. BRD4-L promotes   in the RELA/BRD4 interaction . STAT3-dependent
                                                                                           [54]
            NHEJ DNA repair, which is however inhibited by BRD4-S,   phosphorylation of RELA increases RELA acetylation by
            pointing to the opposite roles of BRD4-L and BRD4-S in   p300/CBP, contributing to constitutive NFκB activity in
            DNA repair machinery.                              tumors [55,56] . It is noteworthy that SETD6 monomethylates
                                                               lysine 310 in RELA and has been demonstrated to
            6. Functions of BRD4 in cancer                     interact with  EHMT1/GLP  histone methyltransferase
            6.1. Expression of BRD4 in cancers                 at chromatin, helping contribute to the control of NFκB
                                                               signaling at target promoters . Activation-dependent
                                                                                        [57]
            Enhanced BRD4 activity in cancer patients leads to   phosphorylation of serine 311 blocks monomethylation
            increased  expression  of  MYC,  NOTCH3,  and  NRG1.  In   of RELA/p65 lysine 310. Taken together, these findings
            addition to a high proliferation rate and genetic instability,   corroborate a close connection between NFκB and BET
            cancer cells expressing BRD4 are capable of epithelial-  protein family signaling through BRD4.
            mesenchymal transition and metastasis, as well as exhibit
            chemotherapy resistance .                          6.3. BRD4 and c-Myc as a couple
                               [24]
              Aberrant promoter hypermethylation often causes   Several cancer types have shown that the oncogene MYC
            BRD4  downregulation in  primary colon  cancer  tumors   is regulated by super-enhancer elements [58-61] . c-Myc
            and cell lines. It is suggested that BRD4 plays a role in   oncoprotein is a central regulator of gene expression that
            human colon cancer by inducing ectopic re-expression   exerts a profound influence on various cellular processes.
            in these colon cancer cell lines; however, more studies are   It has been estimated that a substantial portion of human


            Volume 2 Issue 3 (2023)                         5                        https://doi.org/10.36922/gtm.1442
   21   22   23   24   25   26   27   28   29   30   31